News
BP announced in February that it was doing a U-turn on plans to broaden its portfolio to include a range of renewable energy ...
Asia-Pacific markets traded mostly higher as the latest trade developments between the U.S. and Japan, as well as positive ...
Oil prices posted modest gains in early Asia trade on Thursday, recovering from a multi-day slump as a sharper-than-expected draw in U.S. crude inventories revived bullish sentiment. However, concerns ...
Power generation from clean energy rose globally in the first half of the year, led by the renewables champion China, while power output from fossil fuels remained flat from a year earlier, due to ...
Investors have five big moving stocks from Wednesday to watch. In the solar energy sector, Enphase (ENPH) accelerated its downtrend. ENPH stock lost 14.16% to close at $36.48 after the firm forecast a ...
It was an “up” day for Canada's main stock index on Wednesday, as it was buoyed by renewed optimism for fresh trade agreements between the U.S. and its partner countries after President Donald Trump ...
Canada's main stock index rose on Wednesday, buoyed by renewed optimism for fresh trade agreements between the U.S. and its partner countries after President Donald Trump signaled the possibility of ...
Golden Sky Minerals Corp. (V.AUEN) hit a new 52-week high of 39.5 cents Wednesday. Golden Sky announced the results of its ...
Trump announces trade deal with Japan - Global equity indexes rise as risk sentiment improves - US opens with losses across ...
Petroleum prices were steady on Wednesday after falling for three consecutive sessions as a U.S. tariff deal with Japan improved global trade sentiment. Brent crude futures were down 12 cents, or 0.2% ...
Equities rose in Canada’s largest market on Wednesday, as U.S. President Donald Trump fueled hopes for new deals with U.S. trading partners ahead of the fast-approaching August 1 deadline following an ...
Solid Biosciences Inc. (NASDAQ: SLDB) shares made moderate gains at first. The Charlestown, Mass.-based concern, a clinical stage life sciences company developing precision genetic medicines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results